Our Mission
Puma Biotechnology is a biopharmaceutical company dedicated to the acquisition, development, and commercialization of novel therapeutics for the treatment of cancer.
							News Releases
- Oct. 23, 2025 - Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results Read
 - Oct. 2, 2025 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Read
 - Sept. 4, 2025 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Read
 - Sept. 2, 2025 - Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference Read
 - Aug. 8, 2025 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Read
 - Aug. 7, 2025 - Puma Biotechnology Reports Second Quarter Financial Results Read
 - July 24, 2025 - Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial Results Read
 - July 2, 2025 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Read
 - June 4, 2025 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Read
 - May 8, 2025 - Puma Biotechnology Reports First Quarter Financial Results Read
 - May 6, 2025 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Read
 - April 28, 2025 - Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025 Read
 - April 24, 2025 - Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results Read
 - April 2, 2025 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Read
 - Mar. 26, 2025 - Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025 Read
 - Mar. 5, 2025 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Read
 - Feb. 27, 2025 - Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results Read
 - Feb. 26, 2025 - Puma Biotechnology to Present at TD Cowen’s 45th Annual Health Care Conference Read
 - Feb. 13, 2025 - Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results Read
 - Feb. 5, 2025 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Read
 - Jan. 3, 2025 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Read